Junjun Chu

1.4k citations

23 papers · 1.0k indexed · h-index 16

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Oncology top 10%

Papers in ⓘ

Immunology 9
- Immunotherapy and Immune Responses 5
Oncology 9
- Cancer Cells and Metastasis 3
- CAR-T cell therapy research 3

Co-authors: Rong‐Fu Wang (10 shared papers)Changsheng Xing (9 shared papers)Helen Y. Wang (8 shared papers)Qianquan Ma (2 shared papers)Wenyong Long (2 shared papers)Qing Liu (1 shared paper)Mei Luo (1 shared paper)Yinghua Zhu (5 shared papers)
Journals: Oncotarget (3 papers)Frontiers in Immunology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Nature Communications (1 paper)Cell Host & Microbe (1 paper)
Partner nations: China United States Australia

In The Last Decade

Junjun Chu

23 papers receiving 994 citations

Peers

Countries citing papers authored by Junjun Chu

Since Specialization

Citations

This map shows the geographic impact of Junjun Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjun Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjun Chu more than expected).

Fields of papers citing papers by Junjun Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjun Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjun Chu. The network helps show where Junjun Chu may publish in the future.

Co-authors

The 25 scholars most cited alongside Junjun Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Junjun Chu Line = papers co-authored together Junjun Chu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma Frontiers in Immunology ·Qianquan Ma, Wenyong Long, Changsheng Xing, Junjun Chu, Mei Luo, Helen Y. Wang, Qing Liu, Rong‐Fu Wang	2018	172
2	Microbiota regulate innate immune signaling and protective immunity against cancer Cell Host & Microbe ·Changsheng Xing, Mingjun Wang, Adebusola Alagbala Ajibade, Peng Tan, Chuntang Fu, Lang Chen, Motao Zhu, Zhao-Zhe Hao, Junjun Chu, Xiao Yu, Bingnan Yin, Jiahui Zhu, Wan-Jou Shen, Tianhao Duan, Helen Y. Wang, Rong‐Fu Wang	2021	116
3	Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 Nature Communications ·Yinghua Zhu, Yujie Liu, Chao Zhang, Junjun Chu, Yanqing Wu, Yudong Li, Jieqiong Liu, Qian Li, Shunying Li, Qianfeng Shi, Liang Jin, Jianli Zhao, Dong Yin, Sol Efroni, Fengxi Su, Herui Yao, Erwei Song, Qiang Liu	2018	110
4	Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication Nature Metabolism ·Junjun Chu, Changsheng Xing, Yang Du, Tianhao Duan, Siyao Liu, Pengfei Zhang, Chumeng Cheng, Jill Henley, Xin Liu, Qian Chen, Bingnan Yin, Helen Yicheng Wang, Rong‐Fu Wang	2021	88
5	NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2 Oncotarget ·Pengnan Hu, Junjun Chu, Yanqing Wu, Lijuan Sun, Xiaobin Lv, Yinghua Zhu, Jingjing Li, Qiannan Guo, Chang Gong, Bodu Liu, Shicheng Su	2015	78
6	E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter Oncotarget ·Junjun Chu, Yinghua Zhu, Yujie Liu, Lijuan Sun, Xiaobin Lv, Yanqin Wu, Pengnan Hu, Fengxi Su, Chang Gong, Erwei Song, Bodu Liu, Qiang Liu	2015	57
7	The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1 Cancer Letters ·Chen‐Song Huang, Junjun Chu, Xiao‐Xu Zhu, Jianhui Li, Xi-Tai Huang, Jian‐Peng Cai, Wei Zhao, Xiaoyu Yin	2018	51
8	The Role of APAL/ST8SIA6-AS1 lncRNA in PLK1 Activation and Mitotic Catastrophe of Tumor Cells JNCI Journal of the National Cancer Institute ·Man‐Li Luo, Jingjing Li, Liping Shen, Junjun Chu, Qiannan Guo, Guorun Liang, Wei Wu, Jianing Chen, Rufu Chen, Erwei Song	2019	43
9	Multifunctional nanoparticles for co-delivery of paclitaxel and carboplatin against ovarian cancer by inactivating the JMJD3-HER2 axis Nanoscale ·Jingxin Mo, Li Wang, Xiaojia Huang, Bing Lu, Changye Zou, Lili Wei, Junjun Chu, Paul K. Eggers, Chen Shen, Colin L. Raston, Jun Wu, Lee Yong Lim, Wei Zhao	2017	42
10	Treatment of metastatic non‑small cell lung cancer with NY‑ESO‑1 specific TCR engineered‑T cells in a phase I clinical trial: A case report Oncology Letters ·Yan Xia, Xiao‐Peng Tian, Juntao Wang, Dongjuan Qiao, Xianhao Liu, Xiao Liang, Wenli Liang, Dongcheng Ban, Junjun Chu, Jiaming Yu, Rong‐Fu Wang, Geng Tian, Mingjun Wang	2018	40
11	Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy Journal for ImmunoTherapy of Cancer ·Xin Liu, Yixiang Xu, Wei Xiong, Bingnan Yin, Yuqian Huang, Junjun Chu, Changsheng Xing, Qian Chen, Yang Du, Tianhao Duan, Helen Y. Wang, Ningyan Zhang, John S. Yu, Zhiqiang An, Rong‐Fu Wang	2022	33
12	Interaction between microbiota and immunity and its implication in colorectal cancer Frontiers in Immunology ·Changsheng Xing, Yang Du, Tianhao Duan, Kelly Nim, Junjun Chu, Helen Y. Wang, Rong‐Fu Wang	2022	27
13	Intrinsic negative TCR of superblack carbon aerogel films and their ultrabroad band response from UV to microwave Carbon ·Xiujie Ji, Hongqiang Wang, Tianze Chen, Ting Zhang, Junjun Chu, Ai Du	2020	26
14	PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4 Journal of Molecular Cell Biology ·Wenyong Long, Wei Zhao, Bo Ning, Jing Huang, Junjun Chu, Linfeng Li, Qianquan Ma, Changsheng Xing, Helen Y. Wang, Qing Liu, Rong‐Fu Wang	2018	25
15	Nanoporous Carbon Aerogels for Laser-Printed Wearable Sensors ACS Applied Nano Materials ·Xiujie Ji, Ying Zhong, Chenyue Li, Junjun Chu, Hongqiang Wang, Zheng Xing, Tingting Niu, Zhihua Zhang, Ai Du	2021	21
16	Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration Oncotarget ·Xiaobin Lv, Wei Wu, Xiaofeng Tang, Yanqing Wu, Yinghua Zhu, Yujie Liu, Xiuying Cui, Junjun Chu, Pengnan Hu, Jingjing Li, Qiannan Guo, Zeming Cai, Juan Wu, Kaishun Hu, Nengyong Ouyang	2015	19
17	Terrein performs antitumor functions on esophageal cancer cells by inhibiting cell proliferation and synergistic interaction with cisplatin Oncology Letters ·Yanqing Wu, Yinghua Zhu, Shunrong Li, Minhua Zeng, Junjun Chu, Pengnan Hu, Jingjing Li, Qiannan Guo, Xiaobin Lv, Guofu Huang	2017	15
18	JMJD3 regulates CD4+ T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4 Journal of Clinical Investigation ·Chuntang Fu, Qingtian Li, Jia Zou, Changsheng Xing, Mei Luo, Bingnan Yin, Junjun Chu, Jiaming Yu, Xin Liu, Helen Y. Wang, Rong‐Fu Wang	2019	14
19	Activation of cGAS‐STING by Lethal Malaria N67C Dictates Immunity and Mortality through Induction of CD11b⁺Ly6C^hi Proinflammatory Monocytes Advanced Science ·Yang Du, Yien Luo, Zhiqiang Hu, Jiansen Lu, Xin Liu, Changsheng Xing, Jian Wu, Tianhao Duan, Junjun Chu, Helen Y. Wang, Xin‐zhuan Su, Xiao Yu, Rong‐Fu Wang	2022	11
20	USP3 plays a critical role in the induction of innate immune tolerance EMBO Reports ·Tianhao Duan, Yanchun Feng, Yang Du, Changsheng Xing, Junjun Chu, Jiayu Ou, Xin Liu, Motao Zhu, Qian Chen, Bingnan Yin, Helen Y. Wang, Jun Cui, Rong‐Fu Wang	2023	7

About Junjun Chu

Junjun Chu is a scholar working on Immunology, Oncology, Cancer Research, Biotechnology and Infectious Diseases, having authored 23 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), RNA modifications and cancer (4 papers), Cancer Cells and Metastasis (3 papers), CAR-T cell therapy research (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Research and Treatments (2 papers), Epigenetics and DNA Methylation (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Cancer Research (312 citations), Oncology (256 citations), Immunology (190 citations), Molecular Biology (608 citations) and Genetics (71 citations). Junjun Chu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Rong‐Fu Wang, Changsheng Xing, Helen Y. Wang, Qianquan Ma, Wenyong Long, Qing Liu, Mei Luo, Yinghua Zhu, Tianhao Duan and Bingnan Yin. Their work appears in journals such as Oncotarget, Frontiers in Immunology, JNCI Journal of the National Cancer Institute, Nature Communications and Cell Host & Microbe.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact